Congratulations Scientia Professor Greg Dore

The Kirby Institute is delighted to announce that Greg Dore, Head of the Viral Hepatitis Clinical Research Program, has been appointed UNSW Scientia Professor. 

Appointment as a UNSW Scientia Professor recognises outstanding research contributions and leadership, and is the University’s highest academic accolade.
Greg joined the Kirby Institute in 1995, and following initial research in HIV including a PhD on HIV-related opportunistic infections, he moved into hepatitis C epidemiology and clinical research. His early hepatitis C research defined many aspects of the natural history, including spontaneous viral clearance and liver disease progression. He has established an international leading research program focussing on hepatitis C therapeutic and elimination strategies, particularly among people who inject drugs. He las led many national and international hepatitis C clinical trials, and played a leading role in the 2016 PBS listing of direct-acting antiviral therapy. These highly curative and well tolerated therapies have been widely available since March 2016, with more than 60,000 Australians living with hepatitis C infection initiating treatment. 

Congratulations Scientia Professor Greg Dore on this well-deserved appointment!

Date published: 
Friday, 30 November 2018